These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37033751)

  • 21. [Diagnostic case: Erasmus syndrome associating silica exposure with silicosis and systemic sclerosis].
    Paret M; Cottin V; Loubeyre P; Philit F; Revel D; Cordier JF
    J Radiol; 1995 Dec; 76(12):1127-8. PubMed ID: 8676307
    [No Abstract]   [Full Text] [Related]  

  • 22. [Erasmus syndrome: clinical, tomographic, respiratory function and bronchoalveolar lavage characteristics].
    Cointrel C; Tillie-Leblond I; Lamblin C; Furon D; Tonnel AB; Wallaert B
    Rev Mal Respir; 1997 Jan; 14(1):21-6. PubMed ID: 9082502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Erasmus syndrome: role of specialist palliative care.
    Kuriakose J; Sundararaj JJ; Joseph J; Gladys A; Kurien RB; Manoharan A; As C
    BMJ Support Palliat Care; 2023 Sep; ():. PubMed ID: 37758299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Erasmus' syndrome with pseudo-tumour masses].
    Chaouch N; Mjid M; Zarrouk M; Rouhou SC; Ammous I; Hantous S; Racil H; Chabbou A
    Rev Mal Respir; 2011 Sep; 28(7):924-7. PubMed ID: 21943540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nailfold capillaroscopy for the early diagnosis of the scleroderma spectrum of diseases in patients without Raynaud's phenomenon.
    Hong C; Xiang L; Saffari SE; Low AH
    J Scleroderma Relat Disord; 2022 Jun; 7(2):144-150. PubMed ID: 35585956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Raynaud's phenomenon and positive antinuclear antibodies as first manifestation of POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes): a case report.
    Torres-Saavedra F; León-Sierra L
    BMC Rheumatol; 2022 May; 6(1):26. PubMed ID: 35585632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Silica associated systemic sclerosis: an occupational health hazard.
    Shivakumar DS; Kamath NS; Naik A
    BMJ Case Rep; 2023 Jan; 16(1):. PubMed ID: 36653045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic dyspnea with Raynaud's phenomenon and elevated ANA: A diagnosis of systemic sclerosis sine scleroderma.
    Chong WH; Saha BK; Beegle S
    Am J Med Sci; 2023 Feb; 365(2):198-204. PubMed ID: 35276077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evolution of primary Raynaud's phenomenon (Raynaud's disease) to connective tissue disease.
    Gerbracht DD; Steen VD; Ziegler GL; Medsger TA; Rodnan GP
    Arthritis Rheum; 1985 Jan; 28(1):87-92. PubMed ID: 3871330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A case of mixed connective tissue disease developed into overlap syndrome of progressive systemic sclerosis, systemic lupus erythematosus, polymyositis and Sjögren's syndrome].
    Akiyama Y; Suzuki T; Tanaka M; Kobayashi K; Kagiri T; Ishibashi T; Kitagawa H; Imai F; Hara K; Doi Y
    Arerugi; 1990 Jun; 39(6):542-7. PubMed ID: 2222196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Etiological profile of secondary Raynaud's phenomenon in an internal medicine department. About 121 patients].
    Ben Salem T; Tougorti M; Bziouech S; Lamloum M; Khanfir M; Ben Ghorbel I; Houman MH
    J Med Vasc; 2018 Feb; 43(1):29-35. PubMed ID: 29425538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Juvenile systemic sclerosis: experience from a tertiary care center from India.
    Bagri NK; Raj D; Kaur J; Punia H; Saini I; Lodha R; Kabra SK
    Rheumatol Int; 2017 Oct; 37(10):1687-1691. PubMed ID: 28831595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Arteriopathies as occupational diseases].
    Hachulla E; Hatron PY; Devulder B
    Rev Med Interne; 1993 May; 14(5):329-39. PubMed ID: 8235149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Raynaud's Phenomenon with Focus on Systemic Sclerosis.
    Maciejewska M; Sikora M; Maciejewski C; Alda-Malicka R; Czuwara J; Rudnicka L
    J Clin Med; 2022 Apr; 11(9):. PubMed ID: 35566614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Botulinum toxin type A contribution in the treatment of Raynaud's phenomenon due to systemic sclerosis].
    Serri J; Legré R; Veit V; Guardia C; Gay AM
    Ann Chir Plast Esthet; 2013 Dec; 58(6):658-62. PubMed ID: 22204894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Silica, silicosis, and progressive systemic sclerosis.
    Sluis-Cremer GK; Hessel PA; Nizdo EH; Churchill AR; Zeiss EA
    Br J Ind Med; 1985 Dec; 42(12):838-43. PubMed ID: 3000415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Juvenile systemic sclerosis - observations of one clinical centre.
    Rutkowska-Sak L; Gietka P; Gazda A; Kołodziejczyk B
    Reumatologia; 2021; 59(6):367-372. PubMed ID: 35079180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Research progress of silica-associated autoimmune diseases].
    Xu WJ; Ye Q
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2021 Jan; 39(1):69-73. PubMed ID: 33535350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Longitudinal study of patients with anticentromere antibody.
    Takehara K; Soma Y; Igarashi A; Kikuchi K; Tamaki T; Ishibashi Y
    Dermatologica; 1990; 181(3):202-6. PubMed ID: 2135387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Erasmus syndrome: systemic sclerosis and silicosis co-occurrence.
    Sarı Sürmelİ Z; Oruçoğlu N
    Int J Rheum Dis; 2018 Jun; 21(6):1326-1329. PubMed ID: 29667340
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.